JPWO2019216294A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019216294A5
JPWO2019216294A5 JP2020518289A JP2020518289A JPWO2019216294A5 JP WO2019216294 A5 JPWO2019216294 A5 JP WO2019216294A5 JP 2020518289 A JP2020518289 A JP 2020518289A JP 2020518289 A JP2020518289 A JP 2020518289A JP WO2019216294 A5 JPWO2019216294 A5 JP WO2019216294A5
Authority
JP
Japan
Prior art keywords
methyl
pyridin
imidazo
trifluoromethyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020518289A
Other languages
English (en)
Japanese (ja)
Other versions
JP7235047B2 (ja
JPWO2019216294A1 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/018201 external-priority patent/WO2019216294A1/ja
Publication of JPWO2019216294A1 publication Critical patent/JPWO2019216294A1/ja
Publication of JPWO2019216294A5 publication Critical patent/JPWO2019216294A5/ja
Application granted granted Critical
Publication of JP7235047B2 publication Critical patent/JP7235047B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020518289A 2018-05-08 2019-05-07 アザベンゾイミダゾール化合物及び医薬 Active JP7235047B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018089867 2018-05-08
JP2018089867 2018-05-08
PCT/JP2019/018201 WO2019216294A1 (ja) 2018-05-08 2019-05-07 アザベンゾイミダゾール化合物及び医薬

Publications (3)

Publication Number Publication Date
JPWO2019216294A1 JPWO2019216294A1 (ja) 2021-05-13
JPWO2019216294A5 true JPWO2019216294A5 (https=) 2023-01-19
JP7235047B2 JP7235047B2 (ja) 2023-03-08

Family

ID=68467433

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020518289A Active JP7235047B2 (ja) 2018-05-08 2019-05-07 アザベンゾイミダゾール化合物及び医薬

Country Status (35)

Country Link
US (1) US12319683B2 (https=)
EP (1) EP3792260B1 (https=)
JP (1) JP7235047B2 (https=)
KR (1) KR102819951B1 (https=)
CN (1) CN112368282B (https=)
AU (1) AU2019265134B2 (https=)
BR (1) BR112020022662A2 (https=)
CA (1) CA3099655A1 (https=)
CL (1) CL2020002868A1 (https=)
CO (1) CO2020013848A2 (https=)
DK (1) DK3792260T3 (https=)
EC (1) ECSP20078586A (https=)
ES (1) ES2992256T3 (https=)
FI (1) FI3792260T3 (https=)
HR (1) HRP20241414T1 (https=)
HU (1) HUE068695T2 (https=)
IL (1) IL278517B2 (https=)
LT (1) LT3792260T (https=)
MA (1) MA52587B1 (https=)
MD (1) MD3792260T2 (https=)
MX (1) MX2020011855A (https=)
MY (1) MY202833A (https=)
PE (1) PE20211384A1 (https=)
PH (1) PH12020551873A1 (https=)
PL (1) PL3792260T3 (https=)
PT (1) PT3792260T (https=)
RS (1) RS65996B1 (https=)
SA (1) SA520420487B1 (https=)
SG (1) SG11202011003TA (https=)
SI (1) SI3792260T1 (https=)
SM (1) SMT202400407T1 (https=)
TW (1) TWI868068B (https=)
UA (1) UA126774C2 (https=)
WO (1) WO2019216294A1 (https=)
ZA (1) ZA202007164B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3792260T (pt) 2018-05-08 2024-10-02 Nippon Shinyaku Co Ltd Compostos de azabenzimidazol e produtos farmacêuticos
BR112022008457A2 (pt) * 2019-11-13 2022-07-26 Nippon Shinyaku Co Ltd Agente terapêutico e agente profilático para distúrbios gastrointestinais funcionais e xerostomia
CA3161582A1 (en) 2019-11-13 2021-05-20 Nippon Shinyaku Co., Ltd. Azabenzimidazole compound and medicine
CN118045050B (zh) * 2023-11-16 2025-06-10 中山大学肿瘤防治中心(中山大学附属肿瘤医院、中山大学肿瘤研究所) 一种头颈部放疗患者适用的缓解口腔干燥的组合物及其制备方法
WO2025153078A1 (zh) * 2024-01-17 2025-07-24 盛睿泽华医药科技(苏州)有限公司 可溶性环氧水解酶抑制剂及其应用

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571819A (en) 1994-11-22 1996-11-05 Sabb; Annmarie L. Imidazopyridines as muscarinic agents
NO2005012I1 (no) 1994-12-28 2005-06-06 Debio Rech Pharma Sa Triptorelin og farmasoytisk akseptable salter derav
UA73543C2 (uk) 1999-12-07 2005-08-15 Тераванс, Інк. Похідні сечовини, фармацевтична композиція та застосування похідного при приготуванні лікарського засобу для лікування захворювання, яке опосередковується мускариновим рецептором
JP2007528418A (ja) 2004-03-11 2007-10-11 セラヴァンス, インコーポレーテッド ムスカリンレセプターアンタゴニストとしての有用なジフェニルメチル化合物
TW200538095A (en) 2004-03-11 2005-12-01 Theravance Inc Biphenyl compounds useful as muscarinic receptor antagonists
EP1734820A4 (en) 2004-04-16 2008-01-23 Neurogen Corp Imidazopyrrazine, imidazopyridine, and imidazo-pyrimidine as CRF1 receptor ligands
EP2275095A3 (en) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
ES2274712B1 (es) * 2005-10-06 2008-03-01 Laboratorios Almirall S.A. Nuevos derivados imidazopiridina.
JP5054770B2 (ja) 2006-07-11 2012-10-24 デウン ファーマシューティカル カンパニー リミテッド 新規のビアリールベンゾイミダゾール誘導体及びこれを含む医薬組成物
US8008307B2 (en) 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
GB0706168D0 (en) 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
WO2009092764A1 (en) * 2008-01-24 2009-07-30 Ucb Pharma, S.A. Compounds comprising a cyclobutoxy group
PL2416761T3 (pl) 2009-05-11 2015-07-31 Ratiopharm Gmbh Desfezoterodyna w postaci soli kwasu winowego
WO2011018894A1 (en) 2009-08-10 2011-02-17 Raqualia Pharma Inc. Pyrrolopyrimidine derivatives as potassium channel modulators
JP5667934B2 (ja) * 2010-06-28 2015-02-12 大日本住友製薬株式会社 新規2環性複素環化合物からなる医薬
TWI541243B (zh) 2010-09-10 2016-07-11 拜耳知識產權公司 經取代咪唑并嗒
JP2013545776A (ja) * 2010-12-17 2013-12-26 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 過剰増殖性障害の治療におけるmps−1およびtkk阻害剤として使用するための6置換イミダゾピラジン
CA2821819A1 (en) 2010-12-17 2012-06-21 Marcus Koppitz 6-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
SG11201400102WA (en) 2011-08-24 2014-03-28 Millennium Pharm Inc Inhibitors of nedd8-activating enzyme
JP2013237634A (ja) 2012-05-14 2013-11-28 Dainippon Sumitomo Pharma Co Ltd 縮環イミダゾロン誘導体
GB201302927D0 (en) * 2013-02-20 2013-04-03 Cancer Therapeutics Crc Pty Ltd Compounds
TWI647227B (zh) 2013-02-28 2019-01-11 日商安斯泰來製藥股份有限公司 2-醯胺噻唑衍生物或其鹽
US9951060B2 (en) 2014-06-06 2018-04-24 Astellas Pharma Inc. 2-acylaminothiazole derivative or salt thereof
CN106573928B (zh) 2014-08-26 2020-04-14 安斯泰来制药株式会社 2-氨基噻唑衍生物或其盐
JP6680297B2 (ja) 2015-04-28 2020-04-15 アステラス製薬株式会社 経口投与用医薬組成物
WO2018112840A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. 6, 5-fused heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor
US11136324B2 (en) 2017-03-03 2021-10-05 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Substituted imidazoles as apoptosis signal regulating kinase 1 inhibitors
KR102735800B1 (ko) 2017-12-21 2024-11-28 교린 세이야쿠 가부시키가이샤 야간빈뇨 치료제
JPWO2019189766A1 (ja) 2018-03-30 2021-04-08 持田製薬株式会社 新規ビアリールアミド誘導体
PT3792260T (pt) 2018-05-08 2024-10-02 Nippon Shinyaku Co Ltd Compostos de azabenzimidazol e produtos farmacêuticos
TW202012415A (zh) 2018-05-08 2020-04-01 瑞典商阿斯特捷利康公司 化學化合物
BR112022008457A2 (pt) 2019-11-13 2022-07-26 Nippon Shinyaku Co Ltd Agente terapêutico e agente profilático para distúrbios gastrointestinais funcionais e xerostomia
CA3161582A1 (en) 2019-11-13 2021-05-20 Nippon Shinyaku Co., Ltd. Azabenzimidazole compound and medicine

Similar Documents

Publication Publication Date Title
JPWO2019216294A5 (https=)
US11795164B2 (en) 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer
US12180193B2 (en) Accelerating fibrosarcoma protein degrading compounds and associated methods of use
US10253019B2 (en) Tank-binding kinase inhibitor compounds
US11304946B2 (en) 2-hetarylpyrimidine-4-carboxamides as aryl hydrocarbon receptor antagonists
US10287266B2 (en) Compounds and compositions for inhibiting the activity of SHP2
AU2014291711B2 (en) Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core
US10428044B2 (en) 3-amino-1,5,6,7-tetrahydro-4H-indol-4-ones
US11591311B2 (en) 3-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamides
US8802663B2 (en) Pyrazole oxadiazole derivatives as S1P1 agonists
JP2006503010A5 (https=)
CA3164832A1 (en) 3-(5-methoxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
JP2011515462A5 (https=)
JP2017515844A5 (https=)
HRP20241414T1 (hr) Azabenzimidazolski spojevi i farmaceutski proizvod
US20200283395A1 (en) 2-phenylpyrimidine-4-carboxamides as ahr inhibitors
US20190388421A1 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis
JP2021500332A5 (https=)
CN103237795B (zh) 经取代的噁二唑化合物及其作为s1p1激动剂的用途
US8835470B2 (en) Mandelamide heterocyclic compounds
JP2024534567A5 (https=)
JP2024508817A (ja) B型肝炎ウイルス感染症の処置および予防のためのベンゾチアゾリルビシクロ[1.1.1]ペンタン誘導体
RU2020139649A (ru) Азабензимидазольные соединения и фармкомпозиция
JP2024510762A5 (https=)
JP2014040374A (ja) グリシントランスポーター阻害物質